Research highlightRespir Res: RNA pull-down and ChIP reveal how lncRNA Snhg18 drives pulmonary hypertension
Original article DOI: 10.1186/s12931-026-03707-1· PMID: 42152052This research note is written in Chinese; the key findings below are summarised in English.
Snhg18 is upregulated in hypoxic pulmonary artery smooth muscle cells and lung tissue; silencing it reduces proliferation and vascular remodelling in vitro and in vivo.
ChIP showed that the transcription factor Sp1 binds the Snhg18 promoter and activates its transcription.
RNA pull-down showed Snhg18 binds the m6A reader Hnrnpa2b1, stabilising Eno3 mRNA in an m6A-dependent manner and enhancing glycolysis.
The Snhg18/Hnrnpa2b1/Eno3 axis is proposed as a potential therapeutic target in pulmonary hypertension.
Full article in Chinese →Related products
The ChIP and RNA pull-down experiments in this study map directly onto our interaction kits (RNA pull-down / RIP / ChIP / Co-IP), each supplied with a detailed protocol.
Call us +86 178 3067 4002